EVALUATION OF THE EFFECTIVENESS OF A TUMOR NECROSIS FACTOR INHIBITOR IN THE TREATMENT OF ANKYLOSING SPONDYLITIS

МУХАММАДИЕВА Севара Муродуллаевна, NABIEVA Dildorakhan Abdumalikovna, ZIYAEVA Feruza Kamallidinovna, MIRHAMIDOV Mirziyod Vosilzhonovich, SHIRANOVA Shakhnoza Abdinazarovna

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali · 2023-yil

Annotatsiya

This article is devoted to the effectiveness of treating ankylosing spondylitis (AS), a chronic inflammatory disease of the musculoskeletal system. The study included 53 patients with active AS (BASDAI activity index >4) and failure of standard therapy, which included the TNF-a inhibitor infliximab (INF) at a dose of 3-5 mg/kg intravenously for 0, 2, 6 weeks and next every 8 weeks. In  patients treated with INF, a positive clinical effect was achieved by indicators BASDAI and BASMI scores, as well as a remarkable positive result in dynamics vertebral mobility index and BASFI score. Tolerability of INF patients was satisfactory.

Maqola ma’lumotlari
MualliflarМУХАММАДИЕВА Севара Муродуллаевна, NABIEVA Dildorakhan Abdumalikovna, ZIYAEVA Feruza Kamallidinovna, MIRHAMIDOV Mirziyod Vosilzhonovich, SHIRANOVA Shakhnoza Abdinazarovna
JurnalJournal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
Nashr sanasi2023-04-28
Jild8
Son1
TilRus

Kalit so‘zlar

анкилозирующий спондилоартрит, диагностика, лечение, ингибиторы ФНO-α, инфликсимаб, анкилозловчи спондилоартрит, диагностика, даволаш, ЎНО-α ингибиторлари, инфликсимаб

Ilmiy soha

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali jurnalidan boshqa maqolalar

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar